Related Experiment Videos
Thrombotic occlusion of a Bjork-Shiley mitral valve
The Canadian Journal of Cardiology
|May 1, 1986
Insights
Mechanical cardiac valve thrombosis is a serious complication that can be prevented with proper anticoagulation. This case highlights the risks of discontinuing therapy, leading to near-fatal valve thrombosis.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Mechanical cardiac valves require lifelong anticoagulation to prevent thrombotic complications.
- Prosthetic valve thrombosis (PVT) is a significant risk, particularly with older valve designs.
Observation:
- A patient with a Bjork-Shiley mitral valve experienced near-fatal thrombosis after discontinuing anticoagulant therapy.
- This event underscores the critical role of adherence to anticoagulation protocols.
Findings:
- The incidence of PVT varies by valve type and anatomical location.
- Factors contributing to PVT include inadequate anticoagulation, patient adherence, and valve design.
Implications:
- Maintaining adequate anticoagulation is crucial for preventing mechanical heart valve thrombosis.
- Further research into risk factors and prevention strategies for PVT is warranted.
Abstract:
Thrombosis of a mechanical cardiac valve is a complication potentially preventable by adequate anticoagulation. A patient is described who discontinued anticoagulant therapy, with resultant near-fatal thrombosis of a mitral Bjork-Shiley valve. The literature is reviewed concerning the incidence of thrombotic prosthetic valve occlusion in the various anatomical sites and potential factors contributing to its occurrence.